share_log

CareCloud Files Special Meeting Proxy to Accelerate Growth

CareCloud Files Special Meeting Proxy to Accelerate Growth

CareCloud 文件特別會議代理以加速增長
GlobeNewswire ·  12/09 21:10

SOMERSET, N.J., Dec. 09, 2024 (GLOBE NEWSWIRE) -- CareCloud, Inc. (the "Company" or "CareCloud") (Nasdaq: CCLD CCLDO, CCLDP), a leader in healthcare information technology solutions for medical practices and health systems nationwide, today announced the solicitation of proxies from its common stock (the "Common Stock") shareholders to approve an increase in its authorized shares. This increase is designed to support the Company's growth initiatives and corporate objectives.

新澤西州索梅塞特,2024年12月09日(全球新聞網)-- CareCloud, Inc.("公司"或"CareCloud")(納斯達克:CCLD CCLDO, CCLDP),在全國範圍內爲醫療機構和健康系統提供醫療信息技術解決方案的領導者,今天宣佈向其普通股("普通股")股東征集代理權,以批准增加其授權股份。這一增資旨在支持公司的增長計劃和企業目標。

Focus on Growth

專注於增長

Mahmud Haq, Founder and Executive Chairman of CareCloud's Board of Directors stated, "As CareCloud's largest common stockholder, Founder and Executive Chairman, I enthusiastically support this proposal. Our board and executive team collectively own more than 38% of the Common Stock and we firmly believe that increasing the number of authorized shares is essential to driving our revenue and profits – empowering us to deliver sustained, double-digit growth with a simultaneous, laser-like focus on profitability."

CareCloud董事會的創始人兼執行主席Mahmud Haq表示:「作爲CareCloud最大的普通股股東,創始人兼執行主席,我熱情支持這一提案。我們的董事會和執行團隊共同擁有超過38%的普通股,我們堅信增加授權股份的數量對於推動我們的營業收入和利潤至關重要——使我們能夠實現持續的兩位數增長,同時對盈利能力保持激光般的關注。」

CareCloud, a leading developer and provider of healthcare information technology and AI solutions, has achieved a 23% compound annual growth rate ("CAGR") over the past decade through its focus on acquisitive and organic growth. During the first three quarters of 2024, the Company generated over $10 million in free cash flow and achieved a 50% year-over-year increase in adjusted EBITDA.

CareCloud是一家領先的醫療信息技術和人工智能解決方案開發和提供商,過去十年實現了23%的複合年增長率("CAGR"),通過專注於收購和有機增長。在2024年前三季度,公司創造了超過1000萬的自由現金流,並實現了調整後EBITDA同比增長50%。

The Proposal

提案

The board-supported proposal seeks to increase the Company's authorized shares of Common Stock from 35 million to 85 million. This increase is intended to provide the flexibility needed for strategic growth initiatives, including future acquisitions, and to enable the potential conversion of the Company's outstanding Series A Preferred Stock to Common Stock. Additionally, it supports investments in organic growth and other corporate priorities.

董事會支持的提案旨在將公司的普通股授權股份從3500萬增加到8500萬。此增幅旨在爲戰略增長計劃提供所需的靈活性,包括未來的收購,並使公司未償還的A系列優先股能夠轉換爲普通股。此外,它支持對有機增長和其他公司優先事項的投資。

The Special Meeting of Common Stock Shareholders, which is scheduled for January 27, 2025, will enable holders of the Common Stock as of December 3, 2024 to vote on increasing the Company's authorized shares of Common Stock. Additional information regarding the Proxy is available on the Company's website and at www.sec.gov.

定於2025年1月27日召開的普通股股東特別會議,將使截至2024年12月3日的普通股持有者能夠投票決定增加公司的授權普通股股份。有關代理的信息請訪問公司的官方網站和 www.sec.gov。

How to Vote

如何投票

CareCloud encourages all shareholders to participate and ensure their voices are heard. Shareholders may vote through one of the following methods:

CareCloud 鼓勵所有股東參與並確保他們的聲音被聽到。股東可以通過以下方式投票:

  • E-Vote: Shareholders may visit the website of the Company's transfer agent () and use the identified control number to vote on or before 11:59 pm Eastern Time on January 23, 2025. Alternatively, they may vote online through their investment broker by following their voting instructions.
  • Mail: Shareholders may mark, sign and date their proxy card, then detach it, and return it in the enclosed postage paid envelope. Proxies must be received by January 23, 2025, to be counted.
  • Attend the Special Meeting: Shareholders may attend and vote their shares at the Special Meeting on January 27, 2025.
  • 電子投票:股東可以訪問公司轉讓代理的網站(),並使用識別的控制號碼在 2025 年 1 月 23 日東部時間晚上 11:59 之前投票。或者,他們也可以通過關注投資經紀人的投票說明在線投票。
  • 郵寄:股東可以在代理卡上做記號、簽名並註明日期,然後將其撕下,並放入隨附的郵資已付信封中寄回。代理必須在 2025 年 1 月 23 日之前收到,以便計算。
  • 參加特殊會議: 股東可以參加並在 2025 年 1 月 27 日的特別會議上投票。

About CareCloud

關於CareCloud

CareCloud brings disciplined innovation to the business of healthcare. Our suite of technology-enabled solutions helps clients increase financial and operational performance, streamline clinical workflows and improve the patient experience. More than 40,000 providers count on CareCloud to help them improve patient care while reducing administrative burdens and operating costs. Learn more about our products and services including revenue cycle management (RCM), practice management (PM), electronic health records (EHR), business intelligence, patient experience management (PXM) and digital health at .

CareCloud爲醫療行業帶來了有序的創新。我們的技術驅動解決方案套件幫助客戶提高財務和運營表現,簡化臨床工作流程,並改善患者體驗。超過40,000個服務提供商依賴CareCloud來幫助他們改善患者護理,同時降低行政負擔和運營成本。了解有關我們產品和服務的更多信息,包括營業收入管理(RCM)、實踐管理(PM)、電子健康記錄(EHR)、商業智能、患者體驗管理(PXM)和互聯網醫療。

Follow CareCloud on LinkedIn, Twitter and Facebook.

關注CareCloud LinkedIn, 推特臉書.

Important Additional Information and Where to Find It. CareCloud filed with the SEC a Definitive Proxy Statement on Schedule 14A on December 5, 2024, with respect to its future solicitation of proxies for the Special Meeting of Common Stock Shareholders (including any and all adjournments, postponements, continuations, and reschedulings thereof, the "Special Meeting"). The information contained in this press release is merely a summary of certain relevant portions of the Definitive Proxy Statement and it is important that shareholders review the entirety of the filing. SHAREHOLDERS ARE URGED TO READ THE DEFINITIVE PROXY STATEMENT AND ANY OTHER AMENDMENTS OR SUPPLEMENTS FILED WITH THE SEC CAREFULLY AND IN THEIR ENTIRETY BECAUSE THEY CONTAIN OR WILL CONTAIN IMPORTANT INFORMATION ABOUT CARECLOUD'S FILING. Investors and security holders may obtain copies of these documents and other documents filed with the SEC by CareCloud free of charge through the website maintained by the SEC at www.sec.gov. The Notice of the Special Meeting of Common Stock Shareholders and our Definitive Proxy Statement for the Special Meeting, the Annual Report on Form 10-K for the fiscal year ended December 31, 2023 and our Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2024 are available at www.sec.gov.

重要的額外信息及獲取途徑。CareCloud於2024年12月5日向美國證券交易委員會(SEC)提交了第14A號正式代理聲明,涉及未來對普通股股東的特別會議(包括一切可能的延期、推遲、繼續和重新安排,"特別會議")的代理申請。本新聞稿中包含的信息僅爲正式代理聲明某些相關部分的摘要,股東必須審查全部文件。股東被敦促仔細閱讀正式代理聲明及與SEC提交的任何其他修正或補充文件,因爲這些文件包含或將包含有關CareCloud提交的重要信息。投資者和證券持有人可以通過SEC維護的網站www.sec.gov 免費獲取這些文件及CareCloud提交的其他文件的副本。普通股股東特別會議的通知、我們關於特別會議的正式代理聲明、截至2023年12月31日的財政年度10-K表格年報以及截至2024年9月30日的季度10-Q表格報告均可在www.sec.gov上獲取。

Forward-Looking Statements

前瞻性聲明

This press release contains various forward-looking statements within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements relate to anticipated future events, future results of operations or future financial performance. In some cases, you can identify forward-looking statements by terminology such as "may," "might," "will," "shall," "should," "could", "intends," "expects," "plans," "goals," "projects," "anticipates," "believes," "seeks," "estimates," "predicts," "possible," "potential," "target," or "continue" or the negative of these terms or other comparable terminology.

本新聞稿包含多項符合1995年美國私人證券訴訟改革法案安全港條款的前瞻性聲明。這些聲明涉及預期的未來事件、未來的運營結果或未來的財務表現。在某些情況下,您可以通過術語如「可能」、「或許」、「將」、「應」、「應該」、「能夠」、「打算」、「期望」、「計劃」、「目標」、「項目」、「預期」、「相信」、「尋求」、「估算」、「預測」、「可能」、「潛在」、「目標」或「繼續」以及這些術語的否定形式或其他可比較的術語來識別前瞻性聲明。

Our operations involve risks and uncertainties, many of which are outside our control, and any one of which, or a combination of which, could materially affect our results of operations and whether the forward-looking statements ultimately prove to be correct. Forward-looking statements in this press release include, without limitation, statements reflecting management's expectations for future financial performance and operating expenditures, expected growth, profitability and business outlook, the impact of pandemics on our financial performance and business activities, and the expected results from the integration of our acquisitions.

我們的運營涉及風險和不確定性,其中許多超出了我們的控制範圍,而任何一個風險或其組合都可能對我們的運營結果產生重大影響,以及這些前瞻性聲明最終是否會被證明是正確的。這份新聞稿中的前瞻性聲明包括但不限於反映管理層對未來財務表現和經營支出的期望、預期增長、盈利能力和業務前景、疫情對我們財務表現和業務活動的影響,以及我們收購整合後預期的結果。

These forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are only predictions, are uncertain and involve substantial known and unknown risks, uncertainties and other factors which may cause our (or our industry's) actual results, levels of activity or performance to be materially different from any future results, levels of activity or performance expressed or implied by these forward-looking statements. New risks and uncertainties emerge from time to time, and it is not possible for us to predict all of the risks and uncertainties that could have an impact on the forward-looking statements, including without limitation, risks and uncertainties relating to the Company's ability to manage growth, migrate newly acquired customers and retain new and existing customers, maintain cost-effective global operations, increase operational efficiency and reduce operating costs, predict and properly adjust to changes in reimbursement and other industry regulations and trends, retain the services of key personnel, develop new technologies, upgrade and adapt legacy and acquired technologies to work with evolving industry standards, compete with other companies' products and services competitive with ours, and other important risks and uncertainties referenced and discussed under the heading titled "Risk Factors" in the Company's filings with the Securities and Exchange Commission.

這些前瞻性聲明既不是歷史事實,也不是未來表現的保證。相反,它們僅僅是預測,不確定,並涉及大量已知和未知的風險、不確定性以及其他因素,這些因素可能導致我們(或我們行業的)實際結果、活動水平或表現與這些前瞻性聲明中所表達或暗示的任何未來結果、活動水平或表現存在重大差異。新的風險和不確定性不時出現,我們無法預測所有可能影響前瞻性聲明的風險和不確定性,包括但不限於,與公司管理增長能力、新獲取客戶的遷移和對新客戶和現有客戶的保留、保持具成本效益的全球運營、提高運營效率和降低運營成本、預測和妥善調整報銷及其他行業法規和趨勢變化相關的風險和不確定性、保留關鍵人員的服務、開發新技術、升級和調整傳統技術及收購技術以適應不斷髮展的行業標準、與其他公司產品和服務進行競爭等重要風險和不確定性,以及公司向證券交易委員會提交的文件中「風險因素」標題下提及和討論的其他重要風險和不確定性。

The statements in this press release are made as of the date of this press release, even if subsequently made available by the Company on its website or otherwise. The Company does not assume any obligations to update the forward-looking statements provided to reflect events that occur or circumstances that exist after the date on which they were made.

本新聞稿中的聲明截至本新聞稿發佈之日作出,即使隨後在公司網站或其他方式發佈。公司不承擔任何更新前瞻性聲明的義務,以反映聲明作出後發生的事件或存在的情況。

SOURCE CareCloud

來源:CareCloud

Company Contact:
Norman Roth
Interim Chief Financial Officer and Corporate Controller
CareCloud, Inc.
nroth@carecloud.com

公司聯繫:
諾曼·羅斯
臨時首席財務官兼公司人形機器人-電機控制器
CareCloud公司
nroth@carecloud.com

Investor Contact:
Stephen Snyder
President
CareCloud, Inc.
ir@carecloud.com

投資者聯繫:
斯蒂芬·斯奈德
總裁
CareCloud公司
ir@carecloud.com


声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論